+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

From
Genomics in Cancer Care - Global Strategic Business Report - Product Thumbnail Image

Genomics in Cancer Care - Global Strategic Business Report

  • Report
  • April 2024
  • 93 Pages
  • Global
From
Global Precision Oncology Market Trends and Growth Opportunities - Product Thumbnail Image

Global Precision Oncology Market Trends and Growth Opportunities

  • Report
  • November 2023
  • 78 Pages
  • Global
From
Genomics in Cancer Care Global Market Report 2024 - Product Thumbnail Image

Genomics in Cancer Care Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
Precision Medicine: Global Markets - Product Thumbnail Image

Precision Medicine: Global Markets

  • Report
  • August 2023
  • 65 Pages
  • Global
From
Targeted Therapy Global Market Report 2024 - Product Thumbnail Image

Targeted Therapy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more